<p>Roche Holding AG, through its Genentech division, has announced a major $50 billion investment aimed at expanding U.S. manufacturing, infrastructure, and research and development. The initiative includes breaking ground on a new facility in Holly Springs, North Carolina, and onshoring billions of dollars in research and manufacturing to the United States. This expansion is expected to support over 11,000 jobs, including approximately 6,500 construction positions, and create up to 1,000 highly skilled jobs at new and expanded sites, adding to Genentech’s more than 25,000 U.S. employees. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Roche Holding AG published the original content used to generate this news brief via Business Wire (Ref. ID: 20251219397427) on December 19, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)</p>

RHHBY

<p>Roche Holding AG, through Genentech, announces a $50 billion investment to expand U.S. manufacturing and R&D, including a new facility in North Carolina. This initiative will support over 11,000 jobs, including 6,500 construction positions, and create up to 1,000 skilled jobs, enhancing Genentech's U.S. workforce.</p>

Roche Invests $50 Billion in U.S. Manufacturing and R&D Expansion